Breaking News: Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.

Emerald Health Therapeutics, Inc. (TSX-V: EMH) (OTCQX :EMHTF) announces that it acquired today 1,666,6667 units (the “Units”) of VANC Pharmaceuticals Inc. (OTCQB: NUVPF) (TSX-V: VANC) (“Vanc”) of Suite 810 – 789 West Pender Street, Vancouver, British Columbia, V6C 1H2 at a price of $0.15 per Unit pursuant to a private placement offering (the “Transaction”). Each Unit consists of one common share of Vanc (a “Share”) and one common share purchase warrant. Each whole warrant entitles the holder thereof to purchase one additional Share for a period of 60 months at an exercise price of $0.20.

Immediately before the Transaction, the Company had ownership of nil Shares. Following the Transaction, the Company held ownership of 1,666,667 Shares representing approximately 6.51% of the issued and outstanding Shares. The Company also holds 1,666,667 share purchase warrants for the purchase of an additional 1,666,667 Shares. Assuming the exercise of the warrants, the Company would own a total of 3,333,334 Shares, or approximately 12.23% of Vanc’s then issued and outstanding share capital assuming no other Shares are issued.

Emerald acquired the Units for investment purposes. The Company may sell its Shares either on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors.

This news release is being issued pursuant to Part 3 of National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues of the Canadian Securities Administrators. A copy of the report filed by Emerald in connection with the acquisition of the Units is available on Vanc’s SEDAR profile, and it can also be obtained directly from the Company.

Sponsored Content Release. Click for Full Disclosure

Leave a Comment